Who makes Collagenase SANTYL® Ointment?

Collagenase SANTYL® Ointment is developed by Healthpoint.

What development phase is Collagenase SANTYL® Ointment in?

Collagenase SANTYL® Ointment is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Collagenase SANTYL® Ointment

Healthpoint · FDA-approved active Biologic Quality 5/100

At a glance

Generic name	Collagenase SANTYL® Ointment
Sponsor	Healthpoint
Modality	Biologic
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure Ulcers (PHASE4)
Medihoney and Santyl for Burn Injuries (NA)
Use of Santyl in Diabetic Foot Ulcers (PHASE4)
Use of Santyl Within an Accountable Care Organization (PHASE4)
Santyl Applications to Diabetic Foot Ulcers (PHASE4)
Using Santyl on Diabetic Foot Ulcers (PHASE4)
Long Term Follow Up to Determine the Effects of Collagenase SANTYL Ointment on Scar Formation
Using Santyl or Bacitracin on Second Degree Burns (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Collagenase SANTYL® Ointment CI brief — competitive landscape report
Collagenase SANTYL® Ointment updates RSS · CI watch RSS
Healthpoint portfolio CI